FIRRM and osteosarcoma: Thus, methionine restriction can decrease RNA m6A modification as well as the expression of HNRNPA2B1, both of which can cause the reduction of C1orf112 protein expression and eventually alter the proliferation and metastatic phenotype of osteosarcoma (and potentially other sarcoma) cells.